Discovery of potential PD-L1 small molecule inhibitors as novel cancer therapeutics using machine learning-based QSAR models: A virtual drug repurposing study

被引：0
|
作者：
Siyah, Pinar [1 ]
Durdagi, Serdar [2 ]
Aksoydan, Busecan [1 ]
机构：
[1] Bahcesxehir Univ, Sch Pharm, Istanbul, Turkiye
[2] Bahcesxehir Univ, Dept Biophys, Istanbul, Turkiye
来源：
BIOPHYSICAL JOURNAL | 2023年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
706-Pos
引用
收藏
页码：144A / 144A
页数：1
相关论文
共 43 条
  • [41] A novel combination score based on early serum tumor markers and neutrophil-to-lymphocyte ratio dynamics predicts response to PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer.
    Wang, Jun
    Tang, Yin
    Sun, Yahong
    Yin, Beibei
    Guan, Yaping
    Feng, Dongfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches
    Ajmal, Amar
    Danial, Muhammad
    Zulfat, Maryam
    Numan, Muhammad
    Zakir, Sidra
    Hayat, Chandni
    Alabbosh, Khulood Fahad
    Zaki, Magdi E. A.
    Ali, Arif
    Wei, Dongqing
    PHARMACEUTICALS, 2024, 17 (05)
  • [43] Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study
    Xiong, Anwen
    Li, Wei
    Li, Xingya
    Fan, Yun
    Ma, Zhiyong
    Fang, Jian
    Xie, Qiang
    Zhuang, Wu
    Kang, Mafei
    Wang, Jing
    Xu, Ting
    Xu, Mo
    Zhi, Lihua
    Liu, Qing
    Wang, Ni
    Zhou, Caicun
    EUROPEAN JOURNAL OF CANCER, 2023, 190
12345